Company Sienna Biopharmaceuticals, Inc. Other OTC
Equities
SNNAQ
US82622H1086
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Founder | 59 | 10-06-26 | |
Majed Kheir
COO | Chief Operating Officer | 46 | 15-12-31 |
Silvio Traversa
CTO | Chief Tech/Sci/R&D Officer | 54 | 16-11-30 |
Sean P. Andrews
IRC | Investor Relations Contact | - | - |
General Counsel | 45 | 16-09-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Dennis Fenton
BRD | Director/Board Member | 72 | 16-09-30 |
Founder | 59 | 10-06-26 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 31,050,542 | 30,907,542 ( 99.54 %) | 143,000 ( 0.4605 %) | 99.54 % |
Company contact information
Sienna Biopharmaceuticals, Inc.
30699 Russell Ranch Road Suite 140
91362, Westlake Village
+
Sector
1st Jan change | Capi. | |
---|---|---|
+10.44% | 106B | |
+0.82% | 104B | |
+6.72% | 23.25B | |
-13.89% | 22.5B | |
-6.64% | 18.7B | |
-37.26% | 17.95B | |
-10.98% | 16.99B | |
+8.67% | 14.26B | |
+41.08% | 12.76B |